Subsequently, mutations in both leucine and proline enriched proteoglycan (LEPRE1), encoding P3H1, and peptidylprolyl isomerase b (PPIB), encoding CYPB, were identified in other patients with recessive forms of OI [6]–[13]. Here, P3H1 is linked to osteogenesis imperfecta.